0001104659-24-048900.txt : 20240418
0001104659-24-048900.hdr.sgml : 20240418
20240418164412
ACCESSION NUMBER: 0001104659-24-048900
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240417
FILED AS OF DATE: 20240418
DATE AS OF CHANGE: 20240418
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Buchholz Richard
CENTRAL INDEX KEY: 0001737133
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38468
FILM NUMBER: 24854814
MAIL ADDRESS:
STREET 1: C/O INSPIRE MEDICAL SYSTEMS, INC.
STREET 2: 9700 63RD AVENUE NORTH, SUITE 200
CITY: MAPLE GROVE
STATE: MN
ZIP: 55369
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inspire Medical Systems, Inc.
CENTRAL INDEX KEY: 0001609550
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 261377674
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 WAYZATA BLVD
STREET 2: SUITE 1600
CITY: GOLDEN VALLEY
STATE: MN
ZIP: 55416
BUSINESS PHONE: 763-957-5037
MAIL ADDRESS:
STREET 1: 5500 WAYZATA BLVD
STREET 2: SUITE 1600
CITY: GOLDEN VALLEY
STATE: MN
ZIP: 55416
4
1
tm2412174-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-04-17
0
0001609550
Inspire Medical Systems, Inc.
INSP
0001737133
Buchholz Richard
C/O INSPIRE MEDICAL SYSTEMS, INC.
5500 WAYZATA BLVD., SUITE 1600
GOLDEN VALLEY
MN
55416
0
1
0
0
Chief Financial Officer
1
Common Stock
2024-04-17
4
S
0
15000
230.03
D
28271
D
Common Stock
2024-04-17
4
G
0
500
0
D
27771
D
Common Stock
2024-04-17
4
G
0
125
0
A
1350
I
By daughter
Common Stock
2024-04-17
4
G
0
125
0
A
1350
I
By son
Common Stock
2024-04-17
4
G
0
125
0
A
1350
I
By son
Common Stock
2024-04-17
4
G
0
125
0
A
1350
I
By son
Reflects shares sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $230.00 to $230.82. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Bryan Phillips, Attorney-in-Fact for Richard Buchholz
2024-04-18